Fate Therapeutics, Inc. (FATE) Stock Price History
Historical prices from 2013 to 2026
- 1M
- +58.1%
- 3M
- +162.6%
- YTD
- +205.1%
- 1Y
- +184.9%
- 3Y
- -14.1%
- 5Y
- -48.9%
Loading 10-year price history...
FATE Historical Performance
FATE Annual Returns
Year-by-year price performance · 2013–2026
- 2013 annual price return
- -5.1%
- 2014 annual price return
- -20.9%
- 2015 annual price return
- -34.4%
- 2016 annual price return
- -23.7%
- 2017 annual price return
- +127.1%
- 2018 annual price return
- +103.7%
- 2019 annual price return
- +44.6%
- 2020 annual price return
- +367.0%
- 2021 annual price return
- -34.8%
- 2022 annual price return
- -83.3%
- 2023 annual price return
- -63.2%
- 2024 annual price return
- -55.3%
- 2025 annual price return
- -45.3%
- 2026 annual price return
- +49.5%
FATE Stock Price Trajectory (2013–2026)
As of July 8, 2026, Fate Therapeutics, Inc. (FATE) trades at $3.02, representing a +184.9% return over the past year. The stock has delivered a -96.5% total return over five years (-48.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $121.16 on January 14, 2021. From this peak, FATE has corrected -97.5%, currently trading 111% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers CRSP (+18.7% 1Y), NTLA (+70.0% 1Y), and BEAM (+97.7% 1Y), FATE has outperformed the peer group average. Compare FATE vs CRSP →
FATE Historical Price Data · from 2013
Rows 1–50 of 3,210| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-07-07 | 3.03 | 3.15 | 2.89 | 3.02 | 2.40M | +1.00% |
| 2026-07-06 | 2.88 | 3.12 | 2.84 | 2.99 | 3.38M | +2.40% |
| 2026-07-02 | 3.03 | 3.21 | 2.87 | 2.92 | 4.19M | -3.31% |
| 2026-07-01 | 2.65 | 3.11 | 2.64 | 3.02 | 5.83M | +11.85% |
| 2026-06-30 | 2.42 | 2.72 | 2.39 | 2.70 | 8.27M | +11.57% |
| 2026-06-29 | 2.16 | 2.47 | 2.08 | 2.42 | 5.88M | +15.24% |
| 2026-06-26 | 1.87 | 2.11 | 1.86 | 2.10 | 0 | +12.30% |
| 2026-06-25 | 2.09 | 2.15 | 1.81 | 1.87 | 6.68M | -9.22% |
| 2026-06-24 | 2.17 | 2.34 | 2.05 | 2.06 | 3.59M | -4.63% |
| 2026-06-23 | 2.14 | 2.31 | 2.07 | 2.16 | 7.82M | +0.47% |
| 2026-06-22 | 2.07 | 2.23 | 2.01 | 2.15 | 5.68M | +2.87% |
| 2026-06-18 | 2.00 | 2.13 | 1.93 | 2.09 | 4.00M | +6.63% |
| 2026-06-17 | 1.89 | 2.04 | 1.88 | 1.96 | 1.65M | +3.16% |
| 2026-06-16 | 2.03 | 2.03 | 1.86 | 1.90 | 1.86M | -5.47% |
| 2026-06-15 | 2.06 | 2.06 | 1.95 | 2.01 | 2.84M | -2.43% |
| 2026-06-12 | 1.99 | 2.16 | 1.93 | 2.06 | 4.68M | +4.57% |
| 2026-06-11 | 1.92 | 1.98 | 1.82 | 1.97 | 1.74M | +5.35% |
| 2026-06-10 | 1.91 | 2.02 | 1.87 | 1.87 | 2.02M | -1.58% |
| 2026-06-09 | 1.93 | 2.09 | 1.82 | 1.90 | 1.87M | -0.52% |
| 2026-06-08 | 2.00 | 2.00 | 1.90 | 1.91 | 1.36M | -3.54% |
| 2026-06-05 | 2.16 | 2.17 | 1.96 | 1.98 | 3.88M | -10.41% |
| 2026-06-04 | 2.22 | 2.31 | 2.12 | 2.21 | 3.56M | +0.91% |
| 2026-06-03 | 2.51 | 2.57 | 2.19 | 2.19 | 7.26M | -14.78% |
| 2026-06-02 | 2.71 | 2.77 | 2.55 | 2.57 | 2.85M | -6.20% |
| 2026-06-01 | 2.73 | 2.78 | 2.53 | 2.74 | 7.43M | -3.52% |
| 2026-05-29 | 2.69 | 2.88 | 2.64 | 2.84 | 5.18M | +7.98% |
| 2026-05-28 | 2.37 | 2.67 | 2.31 | 2.63 | 6.53M | +10.97% |
| 2026-05-27 | 2.19 | 2.44 | 2.15 | 2.37 | 7.43M | +10.23% |
| 2026-05-26 | 2.25 | 2.31 | 2.09 | 2.15 | 5.45M | -4.44% |
| 2026-05-22 | 2.14 | 2.31 | 2.08 | 2.25 | 5.89M | +7.14% |
| 2026-05-21 | 1.79 | 2.15 | 1.78 | 2.10 | 5.31M | +14.13% |
| 2026-05-20 | 1.89 | 1.98 | 1.82 | 1.84 | 2.83M | -2.65% |
| 2026-05-19 | 1.70 | 1.91 | 1.59 | 1.89 | 5.86M | +9.25% |
| 2026-05-18 | 1.73 | 1.82 | 1.69 | 1.73 | 2.10M | -1.42% |
| 2026-05-15 | 1.85 | 1.91 | 1.71 | 1.75 | 2.04M | -7.63% |
| 2026-05-14 | 2.02 | 2.20 | 1.90 | 1.90 | 3.74M | -11.01% |
| 2026-05-13 | 2.17 | 2.21 | 1.83 | 2.13 | 5.38M | -5.11% |
| 2026-05-12 | 2.19 | 2.27 | 2.06 | 2.25 | 2.09M | +3.21% |
| 2026-05-11 | 2.36 | 2.43 | 2.15 | 2.18 | 1.15M | -8.79% |
| 2026-05-08 | 2.35 | 2.46 | 2.32 | 2.39 | 2.54M | -1.65% |
| 2026-05-07 | 2.25 | 2.46 | 2.10 | 2.43 | 4.37M | +6.11% |
| 2026-05-06 | 2.29 | 2.41 | 2.17 | 2.29 | 5.86M | -2.97% |
| 2026-05-05 | 2.05 | 2.36 | 1.98 | 2.36 | 10.64M | +31.11% |
| 2026-05-04 | 1.53 | 1.88 | 1.53 | 1.80 | 8.47M | +17.65% |
| 2026-05-01 | 1.25 | 1.59 | 1.24 | 1.53 | 5.00M | +22.40% |
| 2026-04-30 | 1.24 | 1.28 | 1.22 | 1.25 | 741K | +0.81% |
| 2026-04-29 | 1.28 | 1.30 | 1.22 | 1.24 | 906K | -4.62% |
| 2026-04-28 | 1.31 | 1.33 | 1.28 | 1.30 | 737K | -0.76% |
| 2026-04-27 | 1.36 | 1.38 | 1.30 | 1.31 | 1.18M | -1.50% |
| 2026-04-24 | 1.32 | 1.34 | 1.29 | 1.33 | 877K | +0.76% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
FATE — Frequently Asked Questions
Quick answers to the most common questions about buying FATE stock.
How has FATE stock performed recently?
FATE returned +184.9% over the past year, beating its 5-year annualized CAGR of -48.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is FATE's all-time high price?
Fate Therapeutics, Inc. reached $121.16 on 2021-01-14. The 52-week high is $3.21. Current 1-year return of +184.9% places the stock closer to historical peaks.
Where can I download FATE historical price data?
This page provides FATE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2013-2026, downloadable in CSV format.